press center press release

BioDelivery Sciences International, Inc. (BDSI) President and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell



What: BioDelivery Sciences International, Inc. (BDSI) will visit the NASDAQ MarketSite in New York City's Times Square to celebrate the recent approval and upcoming launch of ONSOLIS (fentanyl buccal soluble film). In honor of the occasion, Dr. Mark Sirgo, President and Chief Executive Officer of BDSI and BDSI's management team, will preside over The NASDAQ Stock Market Opening Bell. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Friday, October 9th, 2009 at 9:15 - 9:30 a.m. ET Contacts: Donald Ellis ICR (925) 253-1240 Al Medwar Vice President, Marketing and Corporate Development BioDelivery Sciences International, Inc. (919) 582-9050 NASDAQ MarketSite: Robert Madden (646) 441-5045

Feed Information:

The Opening Bell is available from 9:20 a.m. to 9:35 a.m. on Galaxy 19 C/15, downlink frequency 4000 vertical. The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at (646) 441-5045.

Radio Feed:

An audio transmission of the Opening Bell is also available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Facebook and Twitter:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

For news tweets, please visit our Twitter page at:


A live webcast of the NASDAQ Opening Bell will be available at:


To obtain a hi-resolution photograph of the Market Open, please go to and click on the market open of your choice.

About BioDelivery Sciences International, Inc. (BDSI):

BioDelivery Sciences International, Inc. (Nasdaq:BDSI) is a specialty pharmaceutical company that is focused on developing innovative products to address growing market opportunities, including conditions such as pain. The company utilizes its owned and licensed patented drug delivery technologies to develop, partner, and commercialize new products using proven therapeutics. BDSI's pain franchise currently consists of two products utilizing the Company's patented BEMA buccal soluble film technology: ONSOLIS (fentanyl buccal soluble film) which was approved by FDA on July 16, 2009, for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain, and BEMA Buprenorphine, an analgesic in Phase 2 clinical development with at least one potential target indication for the treatment of moderate to severe pain. The company is working with its BEMA technology and its patented Bioral cochleate technology on products targeted at conditions common to oncology and surgical patients such as pain and infections. The company's headquarters is located in Raleigh, North Carolina. For more information please visit

BDSI(R), BEMA(R) and Bioral(R) are registered trademarks, and ONSOLIS(TM) is a trademark of BioDelivery Sciences International, Inc.


The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with over 3,700 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit *Please follow NASDAQ OMX on Facebook ( and Twitter (


In This Story


Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more